On the other hand, other studies described epigenetic silencing of ZNF185 associated with high grade and metastatic prostate tumours [131], lung tumours and head and neck squamous cell carcinomas [33,132–134]. This evidence concerns the gene ZNF185 and head and neck squamous cell carcinoma.